Asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia in the NOPHO ALL2008 protocol

British Journal of Haematology

Volumn 165, Issue 1, 2014, Pages 126-133

  Raja, Raheel A ^a   Schmiegelow, Kjeld ^a,i   Albertsen, Birgitte K ^b   Prunsild, Kaie ^c   Zeller, Bernward ^d   Vaitkeviciene, Goda ^e   Abrahamsson, Jonas ^f   Heyman, Mats ^g   Taskinen, Mervi ^h   Harila Saari, Arja ^g   Kanerva, Jukka ^h   Frandsen, Thomas L ^a  

^a University of Copenhagen   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c TALLINN CHILDREN S HOSPITAL   (Estonia)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e VILNIUS UNIVERSITY   (Lithuania)

^f QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^g KAROLINSKA INSTITUTE   (Sweden)

^h UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

L asparaginase; Leukaemia; Pancreatitis; Risk factors; Toxicity

Indexed keywords

ASPARAGINASE MACROGOL; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; PREDNISOLONE SODIUM SUCCINATE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; ASPARAGINASE ASSOCIATED PANCREATITIS; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; DEATH; DISEASE SEVERITY; DRUG EXPOSURE; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NECROSIS; PANCREATITIS; PRIORITY JOURNAL; PSEUDOCYST;

L-ASPARAGINASE; LEUKAEMIA; PANCREATITIS; RISK FACTORS; TOXICITY;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PANCREATITIS; POLYETHYLENE GLYCOLS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TREATMENT OUTCOME;

EID: 84896039013     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12733     Document Type: Article

References (27)

1. Appel, I.M., Hop, W.C., van Kessel-Bakvis, C., Stigter, R. & Pieters, R. (2008) L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia. Thrombosis and Haemostasis, 100, 330-337.
2. Banks, P.A., Bollen, T.L., Dervenis, C., Gooszen, H.G., Johnson, C.D., Sarr, M.G., Tsiotos, G.G. & Vege, S.S. (2013) Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut, 62, 102-111.
3. van den Berg, H. (2011) Asparaginase revisited. Leukaemia & Lymphoma, 52, 168-178.
4. Bradley, E.L. III (1993) A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Archives of Surgery, 128, 586-590.
5. Cohen, H., Bielorai, B., Harats, D., Toren, A. & Pinhas-Hamiel, O. (2010) Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer, 54, 703-706.
6. Frandsen, T.L., Heyman, M., Abrahamsson, J., Vettenranta, K., Sberg, A., Vaitkeviciene, G., Pruunsild, K., Toft, N., Birgens, H., Hallbook, H., Quist-Paulsen, P., Griskevicius, L., Helt, L., Hansen, B.V. & Schmiegelow, K. (2014) Complying with the European Clinical Trials directive while surviving the administrative pressure - an alternative approach to toxicity registration in a cancer trial. European Journal of Cancer, 50, 251-259.
7. Hjalgrim, L.L., Rostgaard, K., Hjalgrim, H., Westergaard, T., Thomassen, H., Forestier, E., Gustafsson, G., Kristinsson, J., Melbye, M. & Schmiegelow, K. (2004) Birth weight and risk for childhood leukemia in Denmark, Sweden, Norway, and Iceland. Journal of the National Cancer Institute, 96, 1549-1556.
8. Jaffe, N., Traggis, D., Das, L., Moloney, W.C., Hann, H.W., Kim, B.S. & Nair, R. (1971) L-asparaginase in the treatment of neoplastic diseases in children. Cancer Research, 31, 942-949.
9. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
10. Kearney, S.L., Dahlberg, S.E., Levy, D.E., Voss, S.D., Sallan, S.E. & Silverman, L.B. (2009) Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis. Pediatric Blood & Cancer, 53, 162-167.
11. Knoderer, H.M., Robarge, J. & Flockhart, D.A. (2007) Predicting asparaginase-associated pancreatitis. Pediatric Blood & Cancer, 49, 634-639.
12. Moghrabi, A., Levy, D.E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., Samson, Y., Schorin, M., Dalton, V.K., Lipshultz, S.E., Neuberg, D.S., Gelber, R.D., Cohen, H.J., Sallan, S.E. & Silverman, L.B. (2007) Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood, 109, 896-904.
13. Muller, H.J. & Boos, J. (1998) Use of L-asparaginase in childhood ALL. Critical Reviews in Oncology Hematology, 28, 97-113.
14. Pui, C.H. & Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine, 354, 166-178.
15. Raetz, E.A. & Salzer, W.L. (2010) Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia. Journal of Pediatric Hematology/oncology, 32, 554-563.
16. Raja, R.A., Schmiegelow, K. & Frandsen, T.L. (2012) Asparaginase-associated pancreatitis in children. British Journal of Haematology, 159, 18-27.
17. Samarasinghe, S., Dhir, S., Slack, J., Iyer, P., Wade, R., Clack, R., Vora, A. & Goulden, N. (2013) Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. British Journal of Haematology, 162, 710-713.
18. Schmiegelow, K., Forestier, E., Hellebostad, M., Heyman, M., Kristinsson, J., Soderhall, S. & Taskinen, M. (2010) Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia, 24, 345-354.
19. Silverman, L.B., Gelber, R.D., Dalton, V.K., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., Arkin, S., Declerck, L., Cohen, H.J. & Sallan, S.E. (2001) Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood, 97, 1211-1218.
20. Silverman, L.B., Stevenson, K.E., O'Brien, J.E., Asselin, B.L., Barr, R.D., Clavell, L., Cole, P.D., Kelly, K.M., Laverdiere, C., Michon, B., Schorin, M.A., Schwartz, C.L., O'Holleran, E.W., Neuberg, D.S., Cohen, H.J. & Sallan, S.E. (2010) Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia, 24, 320-334.
21. Sirvent, N., Suciu, S., Rialland, X., Millot, F., Benoit, Y., Plantaz, D., Ferster, A., Robert, A., Lutz, P., Nelken, B., Plouvier, E., Norton, L., Bertrand, Y. & Otten, J. (2011) Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881. European Journal of Cancer, 47, 239-247.
22. Stanulla, M. & Schrappe, M. (2009) Treatment of childhood acute lymphoblastic leukemia. Seminars in Hematology, 46, 52-63.
23. Toft, N., Birgens, H., Abrahamsson, J., Bernell, P., Griskevicius, L., Hallbook, H., Heyman, M., Holm, M.S., Hulegardh, E., Klausen, T.W., Marquart, H.V., Jonsson, O.G., Nielsen, O.J., Quist-Paulsen, P., Taskinen, M., Vaitkeviciene, G., Vettenranta, K., Asberg, A. & Schmiegelow, K. (2013) Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol. European Journal of Haematology, 90, 404-412.
24. Treepongkaruna, S., Thongpak, N., Pakakasama, S., Pienvichit, P., Sirachainan, N. & Hongeng, S. (2009) Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy. Journal of Pediatric Hematology/oncology, 31, 812-815.
25. Vrooman, L.M., Supko, J.G., Neuberg, D.S., Asselin, B.L., Athale, U.H., Clavell, L., Kelly, K.M., Laverdiere, C., Michon, B., Schorin, M., Cohen, H.J., Sallan, S.E. & Silverman, L.B. (2010) Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer, 54, 199-205.
26. Vrooman, L.M., Stevenson, K.E., Supko, J.G., O'Brien, J., Dahlberg, S.E., Asselin, B.L., Athale, U.H., Clavell, L.A., Kelly, K.M., Kutok, J.L., Laverdiere, C., Lipshultz, S.E., Michon, B., Schorin, M., Relling, M.V., Cohen, H.J., Neuberg, D.S., Sallan, S.E. & Silverman, L.B. (2013) Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study-Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. Journal of Clinical Oncology, 31, 1202-1210.
27. Yadav, D. & Lowenfels, A.B. (2013) The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology, 144, 1252-1261.